Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis.

Watanabe, Satoshi; Tanaka, Junta; Ota, Takeshi; Kondo, Rie; Tanaka, Hiroshi; Kagamu, Hiroshi; Ichikawa, Kosuke; Koshio, Jun; Baba, Junko; Miyabayashi, Takao; Narita, Ichiei; Yoshizawa, Hirohisa

Watanabe, Satoshi; Tanaka, Junta; Ota, Takeshi; Kondo, Rie; Tanaka, Hiroshi; Kagamu, Hiroshi; Ichikawa, Kosuke; Koshio, Jun; Baba, Junko; Miyabayashi, Takao; Narita, Ichiei; Yoshizawa, Hirohisa.

Affiliation

Watanabe S; Department of Medicine, Niigata University Medical and Dental Hospital, Niigata City, Japan. satoshimd@yahoo.co.jp

BMC Cancer ; 11: 1, 2011 Jan 01.

Article in En | MEDLINE | ID: mdl-21194487

Subject(s)

Carcinoma, Non-Small-Cell Lung/drug therapy; ErbB Receptors/antagonists & inhibitors; Lung Neoplasms/drug therapy; Quinazolines/therapeutic use; Aged; Diarrhea/chemically induced; Erlotinib Hydrochloride; Exanthema/chemically induced; Female; Gefitinib; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Protein Kinase Inhibitors/adverse effects; Protein Kinase Inhibitors/therapeutic use; Quinazolines/adverse effects; Retreatment; Retrospective Studies; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2011 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google